To assess the efficacy of a progressive aerobic exercise training program on cognitive and everyday function among adults with mild subcortical ischemic vascular cognitive impairment (SIVCI).
This was a proof-of-concept single-blind randomized controlled trial comparing a 6-month, thrice-weekly, progressive aerobic exercise training program (AT) with usual care plus education on cognitive and everyday function with a follow-up assessment 6 months after the formal cessation of aerobic exercise training. Primary outcomes assessed were general cognitive function (Alzheimer's Disease Assessment Scale–Cognitive subscale [ADAS-Cog]), executive functions (Executive Interview [EXIT-25]), and activities of daily living (Alzheimer's Disease Cooperative Study–Activities of Daily Living [ADCS-ADL]).
Seventy adults randomized to aerobic exercise training or usual care were included in intention-to-treat analyses (mean age 74 years, 51% female, n = 35 per group). At the end of the intervention, the aerobic exercise training group had significantly improved ADAS-Cog performance compared with the usual care plus education group (−1.71 point difference, 95% confidence interval [CI] −3.15 to −0.26, p = 0.02); however, this difference was not significant at the 6-month follow-up (−0.63 point difference, 95% CI −2.34 to 1.07, p = 0.46). There were no significant between-group differences at intervention completion and at the 6-month follow-up in EXIT-25 or ADCS-ADL performance. Examination of secondary measures showed between-group differences at intervention completion favoring the AT group in 6-minute walk distance (30.35 meter difference, 95% CI 5.82 to 54.86, p = 0.02) and in diastolic blood pressure (−6.89 mm Hg difference, 95% CI −12.52 to −1.26, p = 0.02).
1. Resistance Training Conference (2016) - Speaker. Paid for my travel and hotel and $500 USD speaker honoraria. 2. Traumatic Brain Injury Conference (2016) - Speaker. Paid for my travel and hotel and $300 speaker honoraria
1. British Journal of Sports Medicine, Senior Associate Editor, 2007 to Present 2. Physical Therapy Journal, Editorial Member, 2012 to Present 3. Journal of Cognitive Enhancement, Editorial Member, 2016 -
1. Non-profit entity - received $600 USD for my expertise on exercise and brain health by a group of multimedia artists from the UK who secured funding from the Wellcome Trust a project called The Average Human. The Average Human is a multi-sensory installation taking science directly to a busy city centre cinema and exhibition complex. Visitors go on a journey of discovery into the daily nutrition, sleep and exercise habits of the average Britain.
1) Canadian Stroke Network, 2009 to 2013, material and operating research support only
Dr. Hsiung has received research support as a clinical trials site investigator from Astra Zeneca, Eli Lilly, Hoffman-La Roche, and TauRx, and has received honorarium for participation in expert review committee with Eli Lilly.
Dr. Hsiung has provided investigator's reports to the British Columbia Ministry of Health on the Alzheimer Disease Therapeutic Initiative.
Dr. Hsiung is supported by a Clinical Genetics Investigatorship award from the CIHR, and has received research funding from the CIHR, Alzheimer Society of Canada, and NIH.
An abstract of preliminary analyses was presented at the Alzheimer's Association International Conference, Washington, DC, July 23, 2015.
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.